首页> 外文期刊>Drug delivery. >Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori.
【24h】

Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori.

机译:漂浮的含乙氧异羟肟酸的生物粘附性微球,可清除幽门螺杆菌。

获取原文
获取原文并翻译 | 示例
       

摘要

A new strategy based on gastric retention is proposed for the treatment of Helicobacter pylori. (H. pylori). A synergism between a floating and a bioadhesive system has been explored. Floating microspheres containing the antiurease drug acetohydroxamic acid (AHA) were prepared by a novel quasi-emulsion solvent diffusion method. The microballons were characterized for size distribution, morphology, drug content, drug release, and in vitro floating property. The microballons were coated with 2% w/v solution of polycarbophil by the air suspension coating method. The bioadhesive property of the microspheres was investigated by the detachment force measurement method. In vitro growth inhibition studies were performed in isolated H. pylori culture. The results suggest that AHA-loaded floating microspheres are superior as potent urease inhibitors whereas urease plays an important role in the colonization of H. pylori. We suggest that an oral dosage containing floating-bioadhesive microspheres may form a useful drug delivery system for the treatment of H. pylori.
机译:提出了一种基于胃retention留的新策略,用于治疗幽门螺杆菌。 (幽门螺杆菌)。已经探索了浮动和生物粘附系统之间的协同作用。通过一种新型的准乳液溶剂扩散法制备了含有抗脲酶药物乙酰氧肟酸(AHA)的漂浮微球。表征了微球的尺寸分布,形态,药物含量,药物释放和体外漂浮性质。通过空气悬浮涂布法将微气球用2%w / v的聚卡波非溶液涂布。通过剥离力测量方法研究了微球的生物粘附性能。在分离的幽门螺杆菌培养物中进行了体外生长抑制研究。结果表明,载有AHA的漂浮微球作为有效的脲酶抑制剂是优越的,而脲酶在幽门螺杆菌的定殖中起着重要作用。我们建议口服包含浮动生物粘附微球的剂量可能会形成一种有用的药物递送系统,用于治疗幽门螺杆菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号